Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

Greenstreet is the CEO of Alnylam Pharmaceuticals. Over the past two decades, scientists have developed a revolutionary new class of medicines with the power to halt or even reverse disease. These ...

Chinese scientists have successfully genetically modified rice to produce coenzyme Q10 (CoQ10), an essential molecule for ...

Recent research highlights an approach in cancer therapy with small molecule drugs targeting immune checkpoints. These innovative drugs overcome the limitations of antibody-based inhibitors, such as ...

Scientists have transformed RNA, a biological molecule present in all living cells, into a biosensor that can detect tiny chemicals relevant to human health. Research by Rutgers University-New ...

Triple-negative breast cancer (TNBC) is exceptionally difficult to treat, in part because the cancer cells lack the hormone receptors that are targeted by many therapies. But now, scientists led by ...

A team of researchers led by University of California, Riverside biomedical scientists has identified a small, previously overlooked small RNA molecule that plays a major role in controlling the ...

The cavity holds a pocket where the small molecule binds. The subunits, being modular, are easily disassembled. In this way, the small-molecule-binding proteins can be treated like Lego blocks and be ...